ABX
Abacus Global Management, Inc.
ABX has the edge over JPM overall, supported by stronger valuation and stronger fundamentals.
JPM
JPMorgan Chase & Co.
JPM has lower modeled downside risk, despite its lower overall score.
ABX Fundamentals
| Metric | Status |
|---|---|
| Healthy | |
| Strong | |
| N/A | |
| N/A |
ABX's revenue and profitability are currently healthy. Free cash flow and net leverage aren't meaningful measures for financial services companies like ABX.
JPM Fundamentals
| Metric | Status |
|---|---|
| Healthy | |
| Strong | |
| N/A | |
| N/A |
JPM's revenue and profitability are currently healthy. Free cash flow and net leverage aren't meaningful measures for financial services companies like JPM.
ABX PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Forward | 7.7x | $8.78 | — |
| Cheap | 25x | $6.77 | -23% |
| Fair | 32x | $8.54 | -2.7% |
| Current | 33x | $8.78 | — |
| Expensive | 209x | $56.46 | +543% |
Historical ranges are pointers, not guarantees.
ABX has the edge over JPM in the historical PE scenario, which offers more potential upside but is not a forecast.
JPM PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Cheap | 9.7x | $231 | -33% |
| Fair | 12x | $287 | -16% |
| Current | 14x | $343 | — |
| Forward | 14x | $343 | — |
| Expensive | 15x | $361 | +5.2% |
Historical ranges are pointers, not guarantees.
JPM's PE is in its expensive range at 14.4x. If earnings grow as analysts expect, today's price would be 13.7x next year's earnings.
ABX Forward outlook
| Metric | Outlook |
|---|---|
| Strongly improving | |
| Strong growth | |
| Strong growth | |
| Stable | |
| Limited | |
| Moderate |
Analysts expect strong earnings and revenue growth for ABX, with profitability holding steady.
JPM Forward outlook
| Metric | Outlook |
|---|---|
| Stable | |
| Growth | |
| Growth | |
| Improving | |
| Limited | |
| Moderate |
Analysts expect earnings and revenue growth for JPM, with profitability improving.
ABX Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $1.14 | +324% |
| Q2 2026 | $0.27 | +$0.37 |
| Q1 2026 | $0.38 | +$0.65 |
| Q4 2025 | $0.36 | +$0.70 |
| Q3 2025 | $0.04 | +$0.26 |
| Q2 2025 | -$0.10 | +$0.04 |
| Q1 2025 | -$0.27 | -$0.25 |
ABX has returned to profit: it earned $0.27 per share over the past year, after losing money the year before.
JPM Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $24.99 | +4.8% |
| Q3 2026 | $23.85 | +18% |
| Q2 2026 | $23.35 | +20% |
| Q1 2026 | $20.89 | +2.5% |
| Q4 2025 | $20.02 | +1.4% |
| Q3 2025 | $20.20 | +12% |
| Q2 2025 | $19.50 | +8.7% |
| Q1 2025 | $20.38 | +23% |
| Q4 2024 | $19.75 | +22% |
JPM has the edge over ABX on earnings, with more consistent year-over-year improvement.
ABX Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q2 2026 | $73M | +30% |
| Q1 2026 | $59.4M | +35% |
| Q4 2025 | $71.9M | +116% |
| Q3 2025 | $63M | +124% |
| Q2 2025 | $56.2M | +93% |
| Q1 2025 | $44.1M | +105% |
| Q4 2024 | $33.2M | +40% |
| Q3 2024 | $28.1M | +33% |
ABX has the edge over JPM on sales, with more consistent year-over-year improvement.
| Quarter | Margin | YoY |
|---|---|---|
| Q2 2026 | 29% | -11 points |
| Q1 2026 | 31% | -17 points |
| Q4 2025 | 32% | +82 points |
| Q3 2025 | 36% | +11 points |
| Q2 2025 | 40% | +17 points |
| Q1 2025 | 48% | +37 points |
| Q4 2024 | -50% | -59 points |
| Q3 2024 | 24% | -5.5 points |
ABX's operating margin was 29% last quarter, down 11 points from the same quarter a year ago.
JPM Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $50.2B | +8.1% |
| Q2 2026 | $57.3B | +28% |
| Q1 2026 | $49.8B | +10% |
| Q4 2025 | $45.8B | +7.1% |
| Q3 2025 | $46.4B | +8.8% |
| Q2 2025 | $44.9B | -11% |
| Q1 2025 | $45.3B | +8.1% |
| Q4 2024 | $42.8B | +11% |
JPM's revenue has grown year over year for five quarters in a row: $50.2B last quarter, up 8.1% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 40% | -0.2 points |
| Q2 2026 | 48% | +7.3 points |
| Q1 2026 | 41% | +0.5 points |
| Q4 2025 | 37% | -3.2 points |
| Q3 2025 | 40% | +0.6 points |
| Q2 2025 | 41% | -6 points |
| Q1 2025 | 41% | -0.6 points |
| Q4 2024 | 41% | +11 points |
JPM has the edge over ABX on profitability, with a higher operating margin.
ABX Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q2 2026 | $38.4M | -49% |
| Q1 2026 | $91.6M | +$153.4M |
| Q4 2025 | -$7.6M | +$84.6M |
| Q3 2025 | -$32.9M | +$19.6M |
| Q2 2025 | $75.7M | +$142.7M |
| Q1 2025 | -$61.8M | -3036% |
| Q4 2024 | -$92.2M | -$78.7M |
| Q2 2024 | -$67M | -$29.1M |
ABX has the edge over JPM on cash generation, producing positive trailing cash flow while its opponent burns cash.
JPM Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $33.2B | +$78.4B |
| Q2 2026 | -$25.3B | -186% |
| Q1 2026 | -$211.8B | +$40.1B |
| Q4 2025 | $119.7B | -19% |
| Q3 2025 | -$45.2B | +$28.9B |
| Q2 2025 | $29.5B | -23% |
| Q1 2025 | -$251.8B | -$97.7B |
| Q4 2024 | $147.8B | +145% |
JPM's free cash flow was −$84.2B over the past year, against −$120B the year before. Free cash flow isn't a meaningful measure for financial services companies like JPM.
ABX Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | -1.1% | -1.1M shares |
| 1 year | +1.1% | +1.1M shares |
| 3 years | +128% | +55.3M shares |
ABX has 98M diluted shares, up 1.1% from a year ago, despite $33M in buybacks over the past year.
| Quarter | Spent |
|---|---|
| Q2 2026 | $9.9M |
| Q1 2026 | $14.5M |
| Q4 2025 | $5.5M |
| Q3 2025 | $3.2M |
| Q2 2025 | $35.1M |
| Q1 2025 | — |
| Q4 2024 | — |
| Q3 2024 | — |
ABX spent $33M buying back its own shares over the past year, down 5.6% from the year before.
JPM Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | -0.4% | -11.2M shares |
| 1 year | -3.1% | -84.6M shares |
| 3 years | -8.5% | -249M shares |
| 5 years | -11% | -322M shares |
| Available history | -17% | -547M shares |
JPM has the edge over ABX on shareholder dilution, with a more favorable share count trend.
| Quarter | Spent |
|---|---|
| Q3 2026 | $1.1B |
| Q2 2026 | $6.8B |
| Q1 2026 | $8.3B |
| Q4 2025 | $8.3B |
| Q3 2025 | $8.3B |
| Q2 2025 | $7.5B |
| Q1 2025 | $7.5B |
| Q4 2024 | $4.3B |
JPM spent $24.5B buying back its own shares over the past year, down 11% from the year before.
ABX Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q2 2026 | 3.0x | Elevated |
| Q1 2026 | 2.8x | Moderate |
| Q4 2025 | 3.4x | Elevated |
| Q3 2025 | 4.9x | High |
| Q2 2025 | -1.5x | Net Cash |
| Q1 2025 | -1.5x | Net Cash |
| Q4 2024 | -18.7x | Net Cash |
| Q3 2024 | -0.2x | Net Cash |
ABX's net debt is about 3.0 years of its operating earnings (EBITDA), after holding more cash than debt a year ago. Net leverage isn't a meaningful measure for financial services companies like ABX.
JPM Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | 0.5x | Very low |
| Q2 2026 | 0.5x | Very low |
| Q1 2026 | 0.6x | Very low |
| Q4 2025 | 0.5x | Very low |
| Q3 2025 | 0.6x | Very low |
| Q2 2025 | 0.5x | Very low |
| Q1 2025 | 0.5x | Very low |
| Q4 2024 | 0.4x | Very low |
JPM has the edge over ABX on leverage, with a lower net debt burden relative to earnings.
ABX Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 48.3 | Neutral |
| Stochastic | 35.8 | Neutral |
ABX's weekly RSI is 48 (neutral) and its Stochastic is 36 (neutral).
JPM Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 54.8 | Neutral |
| Stochastic | 31.5 | Neutral |
JPM's weekly RSI is 55 (neutral) and its Stochastic is 31 (neutral).
ABX PE vs Financial Services Sector
| Metric | ABX | Sector median | Relative |
|---|---|---|---|
| PE | 33x | 13x | 150% above |
| PE % | 53 | 62 | 9 pts below |
ABX is trading at 33x earnings, a 150% premium to the Financial Services sector's median of 13x.
JPM PE vs Financial Services Sector
| Metric | JPM | Sector median | Relative |
|---|---|---|---|
| PE | 14x | 13x | 10% above |
| PE % | 76 | 63 | 13 pts above |
JPM has the edge over ABX on valuation relative to its sector.
ABX Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $8.36 | 5% above |
| 20 week MA | $9.35 | 6.1% below |
| 50 week MA | $8.97 | 2.1% below |
| 100 week MA | $7.90 | 11% above |
| 200 week MA | $8.72 | 0.7% above |
ABX's trend is mixed: it's above three of its five weekly moving averages, and 0.7% above its 200-week average.
JPM Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $336.8 | 1.8% above |
| 20 week MA | $345.3 | 0.7% below |
| 50 week MA | $323.2 | 6.1% above |
| 100 week MA | $298.9 | 15% above |
| 200 week MA | $236.6 | 45% above |
JPM has the edge over ABX on trend strength, trading above more of its moving averages.
ABX Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $9.76 | $9.98 | +2.3% |
| 2021 | $9.98 | $9.86 | -1.2% |
| 2022 | $9.86 | $10.1 | +2.5% |
| 2023 | $10.1 | $9.66 | -4.5% |
| 2024 | $9.66 | $7.75 | -20% |
| 2025 | $7.75 | $8.50 | +9.7% |
| 2026 YTD | $8.50 | $8.78 | +3.3% |
ABX has finished lower in three of the last six years. It's up 3.3% so far in 2026.
JPM Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $139.1 | $124.5 | -11% |
| 2021 | $124.5 | $157.3 | +26% |
| 2022 | $157.3 | $131.3 | -17% |
| 2023 | $131.3 | $170.1 | +30% |
| 2024 | $170.1 | $241.2 | +42% |
| 2025 | $241.2 | $327.9 | +36% |
| 2026 YTD | $327.9 | $342.8 | +4.5% |
JPM has the edge over ABX on returns for 2026, with the stronger performance.